Blog Archive

Blog Archive

Tuesday, May 10, 2011

postheadericon Risks to patients grow with FDA labeling delays

An estimated 3 million people living in the United States have an inherited condition known as celiac disease, an autoimmune disorder triggered by ingesting gluten. One of the world’s most common genetic conditions, it is likely the only one for which the patient remains at risk, each and every day, even when he or she strictly follows the medically prescribed course of treatment, a strict gluten-free diet. 

Congress sought to address this problem when it passed the Food Allergen Labeling and Consumer Protection Act (FALCPA) in 2004. Seven years later, the risk to patients has grown exponentially, as regulations tasked to the FDA remain to be completed and new research indicates another 18 million people have gluten sensitivity also requiring a strict gluten-free diet.  

Read more...

0 ความคิดเห็น: